Research
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
Marc A. Rodger, Susan R. Kahn, Philip S. Wells, David A. Anderson, Isabelle Chagnon, Grégoire Le Gal, Susan Solymoss, Mark Crowther, Arnaud Perrier, Richard White, Linda Vickars, Tim Ramsay, Marisol T. Betancourt and Michael J. Kovacs
CMAJ August 26, 2008 179 (5) 417-426; DOI: https://doi.org/10.1503/cmaj.080493
Marc A. Rodger MD MSc
Susan R. Kahn MD MSc
Philip S. Wells MD MSc
David A. Anderson MD
Isabelle Chagnon MD
Grégoire Le Gal MD PhD
Susan Solymoss MD
Mark Crowther MD
Arnaud Perrier MD
Richard White MD
Linda Vickars MD
Tim Ramsay PhD MSc
Marisol T. Betancourt MD MSc
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
Marc A. Rodger, Susan R. Kahn, Philip S. Wells, David A. Anderson, Isabelle Chagnon, Grégoire Le Gal, Susan Solymoss, Mark Crowther, Arnaud Perrier, Richard White, Linda Vickars, Tim Ramsay, Marisol T. Betancourt, Michael J. Kovacs
CMAJ Aug 2008, 179 (5) 417-426; DOI: 10.1503/cmaj.080493
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
Marc A. Rodger, Susan R. Kahn, Philip S. Wells, David A. Anderson, Isabelle Chagnon, Grégoire Le Gal, Susan Solymoss, Mark Crowther, Arnaud Perrier, Richard White, Linda Vickars, Tim Ramsay, Marisol T. Betancourt, Michael J. Kovacs
CMAJ Aug 2008, 179 (5) 417-426; DOI: 10.1503/cmaj.080493
Jump to section
Related Articles
Cited By...
- Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trial
- Standardized Data Elements for Patients with Acute Pulmonary Embolism: A Consensus Report from the Pulmonary Embolism Research Collaborative
- Elevated plasma Complement Factor H Regulating Protein 5 is associated with venous thromboembolism and COVID-19 severity
- Contribution of the elevated thrombosis risk of males to the excess male mortality observed in COVID-19: an observational study
- Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism: results from the REVERSE study
- Does the elevated (thrombosis risk of males relative to females help account for the excess male mortality observed in Covid-19? An observational study
- Management of Patients With Venous Thromboembolism After the Initial Treatment Period
- Antithrombotic Management of Venous Thromboembolism: JACC Focus Seminar
- Pulmonary embolism: update on management and controversies
- Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
- Extended treatment of venous thromboembolism: a systematic review and network meta-analysis
- Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: protocol for a systematic review and meta-analysis of individual participant data
- Who should get long-term anticoagulant therapy for venous thromboembolism and with what?
- Who should get long-term anticoagulant therapy for venous thromboembolism and with what?
- The authors respond to "Thrombophilia testing in venous thromboembolism"
- Update on the management of venous thromboembolism
- A Test in Context: D-Dimer
- Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis
- Stopping anticoagulation in a woman with unprovoked venous thromboembolism
- Optimizing diagnostic testing for venous thromboembolism
- Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat
- Thrombosis in the setting of obesity or inflammatory bowel disease
- Thrombosis in the setting of obesity or inflammatory bowel disease
- Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment
- Personalized medicine in thrombosis: back to the future
- Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE
- Guided duration of anticoagulation after unprovoked venous thromboembolism using D-dimer testing
- Management of Pulmonary Embolism: An Update
- How I treat recurrent deep-vein thrombosis
- Secondary Prevention of Venous Thromboembolism: One Regimen May Not Fit All
- Predicting recurrence after unprovoked venous thromboembolism: prospective validation of the updated Vienna Prediction Model
- Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval Project
- New insights into treatment of venous thromboembolism
- How Long Is Long Enough? Extended Anticoagulation for the Treatment of Cancer-Associated Deep Vein Thrombosis
- D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study
- Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis
- Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism
- Sex Difference in Risk of Second but Not of First Venous Thrombosis: Paradox Explained
- d-Dimer Levels Over Time and the Risk of Recurrent Venous Thromboembolism: An Update of the Vienna Prediction Model
- Thrombophilia Testing in Women with Venous Thrombosis: The 4 P's Approach
- Should the presence of an antiphospholipid antibody affect the duration of anticoagulant treatment in patients with venous thromboembolism?
- Risk assessment for recurrence and optimal agents for extended treatment of venous thromboembolism
- Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review
- Management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE guidance
- Identifying Risk Factors for Venous Thromboembolism
- Managing pulmonary embolism using prognostic models: future concepts for primary care
- Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials
- Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
- Duration of Anticoagulation: Applying the Guidelines and Beyond
- Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism: The Vienna Prediction Model
- A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families
- Preventing recurrent venous thromboembolism
- Venous Thromboembolism: Risk Factors for Recurrence
- Duration of Anticoagulant Therapy for Unprovoked Venous Thrombosis
- Stopping anticoagulant therapy after an unprovoked venous thromboembolism